On August 2019, China modified and relaxed the laws regarding the import of drugs. Previously, China considered foreign drugs as fake, counterfeit drugs even though they came with a legal… Continue Reading
REGONAT (Generic Regorafenib) Launches in India for Colorectal Cancer Treatment.
About Regonat (Generic Regorafenib) Regonat (generic Regorafenib) 40 mg tablet is a medicine is an anti-cancer medication manufactured by Natco Pharma in India. It functions by suppressing the action of… Continue Reading
Emcure Eribilin (Generic Eribulin) Launches In India at 40% Lower Cost for Breast Cancer
Emcure ERIBILIN is one of the world first generic version of Eisai Pharmaceutical’s Halaven (Eribulin) that is used for the treatment of metastatic breast cancer. ERIBILIN has been developed by… Continue Reading
The slight decline in Hepatitis C diagnoses in Europe
According to the data of the European Surveillance, a decrease of 10% is seen in the cases of one of the most severe diseases known as Hepatitis C during the… Continue Reading
390 Cancer drugs to become cheaper in India, NPPA caps trade margin of 42 drugs
Cancer drugs to become cheaper in India Recently NPPA caps trade margins for 42 anti-cancer drugs. This is very good initiatives taken by the government. As per the government now… Continue Reading